Primmune Therapeutics

‌

Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Their goal is to improve the response rate of patients to current and future immunotherapy medicines.

Industries

Biotechnology

Headquarters

San Diego, United States

Employees

1-10

Links

Org chart

Charles McDermott

Chairman, President & CEO

Collapse

Richard Daniels

Chief Operating Officer

Paulo Rangel

Chief Business Officer & Co-Founder

James Appleman

SVP, R&D & CSO Co-Founder, Director

Curtis Scribner

Chief Medical Officer

Scott Zook

Senior Vice President Global Manufacturing

Randy Adams

Senior Advisor Commercial Strategy

Board & advisors

Director

Director

Director

Clinical Advisor

Clinical Advisor

Clinical Advisor

Scientific Advisor

Clinical Advisor

Outside Counsel

Teams

Leadership Team

6 people · 0 jobs

Clinical Advisors Team

4 people · 0 jobs

Legal and Governance Team

3 people · 0 jobs

Research and Development Team

3 people · 0 jobs

Offices

HQ
5 people · 0 jobs
+1

Similar companies

Gilead Sciences

159 followers

Regeneron

130 followers

Illumina

79 followers

Agilent Technologies

81 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

GRAIL

28 followers

Cytiva

16 followers

PerkinElmer

12 followers

Editas Medicine

5 followers

Organogenesis

5 followers

Explore companies